Skymab participated in BioSpring Europe 2026 to engage with international investors and pharmaceutical companies and explore strategic collaborations supporting the development of its next-generation ADC pipeline and platform technologies.
Skymab participated in BioSpring Europe 2026 to engage with international investors and pharmaceutical companies and explore strategic collaborations supporting the development of its next-generation ADC pipeline and platform technologies.